Eli Lilly said preliminary data from a late-stage study showed its weight-loss drug significantly reduced the risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight.
Related Posts
FTC Sues PepsiCo, Alleging It Gave Walmart Unfair Pricing Advantage
- staff
- January 17, 2025
- 0
Outgoing agency Chair Lina Khan has filed a raft of measures during her last week in office.
Hermes Bucks Luxury Slowdown With Higher Sales But Flags Weakness in China
The Birkin handbag maker reported higher sales for the second quarter, with wealthy customers helping it defy a global slowdown in demand that is troubling […]
Advance Auto Parts to Sell Worldpac to Carlyle for $1.5 Billion
Advance Auto Parts has agreed to sell its Worldpac subsidiary to Carlyle Group for $1.5 billion in cash.